Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine

Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine

The purpose of this article is to provide a focused overview of the current use of positron emission tomography (PET) molecular imaging in the burgeoning era of personalized medicine in the treatment of patients with glioma. Specifically, we demonstrate the utility of PET imaging as a tool for perso...

Full description

Bibliographic Details
Main Authors: Ramon F. Barajas, Kenneth A. Krohn, Jeanne M. Link, Randall A. Hawkins, Jennifer L. Clarke, Miguel H. Pampaloni, Soonmee Cha
Format: Article
Language:English
Published: MDPI AG 2016-10-01
Series:Biomedicines
Subjects:
glioma
progression
pseudoprogression
FMISO
PET
MRI
bevacizumab
reduced diffusion
ADC
Online Access:http://www.mdpi.com/2227-9059/4/4/24

Internet

http://www.mdpi.com/2227-9059/4/4/24

Similar Items